MDBI.F Stock Overview
TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
TrivarX Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.018 |
| 52 Week High | AU$0.028 |
| 52 Week Low | AU$0.01 |
| Beta | 0.81 |
| 1 Month Change | -29.15% |
| 3 Month Change | n/a |
| 1 Year Change | 9.38% |
| 3 Year Change | -87.50% |
| 5 Year Change | -93.66% |
| Change since IPO | -99.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| MDBI.F | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 1.6% |
| 1Y | 9.4% | -5.9% | 25.1% |
Return vs Industry: MDBI.F exceeded the US Healthcare Services industry which returned -5.9% over the past year.
Return vs Market: MDBI.F underperformed the US Market which returned 25.1% over the past year.
Price Volatility
| MDBI.F volatility | |
|---|---|
| MDBI.F Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.8% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MDBI.F's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine MDBI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | n/a | n/a | trivarx.com |
TrivarX Limited, a health technology company, assists in the detection and screening of mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023.
TrivarX Limited Fundamentals Summary
| MDBI.F fundamental statistics | |
|---|---|
| Market cap | US$7.83m |
| Earnings (TTM) | -US$2.47m |
| Revenue (TTM) | US$12.84k |
592.5x
P/S Ratio-3.1x
P/E RatioIs MDBI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MDBI.F income statement (TTM) | |
|---|---|
| Revenue | AU$19.42k |
| Cost of Revenue | -AU$1.00 |
| Gross Profit | AU$19.43k |
| Other Expenses | AU$3.75m |
| Earnings | -AU$3.74m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | 100.01% |
| Net Profit Margin | -19,230.59% |
| Debt/Equity Ratio | 0% |
How did MDBI.F perform over the long term?
See historical performance and comparison